Using mindfulness to help adolescents with depression and insulin resistance
Mindfulness-Based Intervention for Depression and Insulin Resistance in Adolescents
This study is looking at how mindfulness practices can help teenagers who are feeling depressed and at risk for type 2 diabetes by teaching them to manage their emotions and stress better, which could lead to healthier habits and improved well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-11015986 on NIH RePORTER |
What this research studies
This research investigates how mindfulness-based interventions can help adolescents who are experiencing depression and are at risk for type 2 diabetes (T2D). The approach focuses on reducing insulin resistance, which is a precursor to T2D, by addressing depression symptoms that may contribute to unhealthy behaviors and stress physiology. By participating in mindfulness practices, adolescents may learn to manage their emotions and stress better, potentially leading to improved health outcomes. The study aims to evaluate the effectiveness of this intervention in a controlled setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents experiencing symptoms of depression and showing signs of insulin resistance.
Not a fit: Patients who do not have symptoms of depression or are not at risk for insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective way to reduce the risk of type 2 diabetes in adolescents by addressing both mental health and physical health simultaneously.
How similar studies have performed: Previous research has shown promising results for mindfulness-based interventions in improving mental health, but this specific approach targeting insulin resistance in adolescents is relatively novel.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Shomaker, Lauren Berger — Colorado State University
- Study coordinator: Shomaker, Lauren Berger
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.